Pancreatic neuroendocrine tumor with extensive vascularisation and parathyroid hormone-related protein (PTHrP) - Associated hypercalcemia of malignancy

Experimental and Clinical Endocrinology and Diabetes

Volumn 109, Issue 7, 2001, Pages 378-385

  Clemens, P ^a   Gregor, M ^a   Lamberts, R ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Humoral hypercalcemia of malignancy; Neuroendocrine pancreatic tumor; Parathyroid hormone related peptide; Tumor vascularization

Indexed keywords

DOXORUBICIN; PARATHYROID HORMONE RELATED PROTEIN; SOMATOSTATIN DERIVATIVE; STREPTOZOCIN;

ADULT; ARTICLE; CASE REPORT; CATHETER ABLATION; DISEASE COURSE; HUMAN; HYPERCALCEMIA; MALE; NEUROENDOCRINE TUMOR; PANCREAS CARCINOMA; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN SECRETION; TUMOR GROWTH; TUMOR VASCULARIZATION;

ADULT; CARCINOMA, NEUROENDOCRINE; FATAL OUTCOME; HUMANS; HYPERCALCEMIA; MALE; NEOVASCULARIZATION, PATHOLOGIC; PANCREATIC NEOPLASMS; PARATHYROID HORMONE-RELATED PROTEIN; PROTEINS;

EID: 0034764046     PISSN: 09477349     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2001-17411     Document Type: Article

References (44)

1. Parathyroid hormone-like peptide shares features with members of the early response gene family: Rapid induction by serum, growth factors, and cycloheximide
2. Programmed cell death of chondrocytes and aberrant chondrogenesis in mice homozygous for parathyroid hormone-related peptide gene deletion
3. Case ceport: Lanreotide in the management of hypercalcemia of malignancy
4. Intractable hypercalcemia due to a metastatic carcinoid secreting parathyroid hormone-related peptide and interleukin-6: Response to octreotide
5. Radiofrequency ablation: A minimally invasive technique with multiple applications
6. Circulating levels of midregional parathyroid hormone-related protein in hypercalcemia of malignancy
7. Diagnostische bedeutung von parathormon-related-protein bei tumorpatienten mit hypercalcämie
8. Levels of PTHrP in hypercalcemia of malignancy are not lowered by treatment with the biphosphonate BM 21.0955
9. Pancreatic islet cell carcinoma with hypercalcemia: Complete remission 5 years after surgical excision and chemotherapy
10. Humoral hypercalcemia of cancer. Identification of a novel parathyroid hormone-like peptide
11. Increased serum levels of parathyroid hormone-like protein in malignancy-associated hypercalcemia
12. Identification of a novel 17000-dalton parathyroid hormone-like adenylate cyclase-stimulating protein from a tumor associated with humoral hypercalcemia of malignancy
13. Immunocytochemical characterization of circulating parathyroid hormone-related protein in patients with humoral hypercalcemia of cancer
14. Positional cloning of the gene for multiple endocrine neoplasia-type I
15. The parathyroid hormone-related protein associated with malignancy is secreted by neuroendocrine tumors
16. Amino-terminal parathyroid hormone-related protein specific binding and cytosolic calcium responses in rat insulinoma cells
17. Native and a synthetic analogue of the malignancy associated parathyroid hormone-like protein have in vitro transforming growth factor-like properties
18. Parathyroid hormone-related peptide in plasma of patients with hypercalcemia and malignant lesions
19. Long-term follow-up of two patients with metastatic neuroendocrine tumours treated with octreotide
20. Humoral hypercalcemia in patients with colorectal carcinoma
21. Targeted overexpression of parathyroid hormone related protein (PTHrP) to vascular smooth muscle in transgenic mice lowers blood pressure and alters vascular contractility
22. Intractable hypercalcemia due to parathyroid hormone-related peptide secretion by a carcinoid tumour
23. Malignant islet cell tumor associated with hypercalcemia
24. Parathyroid hormone-like peptide in pancreatic endocrine carcinoma and adenocarcinoma associated with hypercalcemia
25. Parathyroid hormone-related peptide mediates hypercalcemia in an islet cell tumor of the pancreas
26. Streptozocin-doxorubicin, streptozocin-fluorouracil, or chlorozotocin in the treatment of advanced islet-cell carcinoma
27. Hypotension and cardiac stimulation due to the parathyroid hormone-related protein, humoral hypercalcemia of malignancy factor
28. Neuroendocrine gastointestinal tumors - A condensed overview of diagnosis and treatment
29. Evidence that implicates the parathyroid hormone-related peptide in vascular stenosis: Increased gene expression in the intima of injured rat carotid arteries and human restenotic coronary lesions
30. Progressive pancreatic islet hyperplasia in the islet-targeted, parathyroid hormone-related protein-overexpressing mouse
31. Pancreatic islet cell carcinoma with hypercalcemia. Primary hyperparathyreoidism or humoral hypercalcemia of malignancy
32. Expression and processing of parathyroid hormone-related protein in a pancreatic endocrine cell tumour associated with hypercalcaemia
33. Parathormone-related-protein. Ein neues calciumregulierendes Hormon und seine Bedeutung für die Tumorhypercalcämie
34. Parathyroid hormone-related protein and hypercalcemia in pancreatic neuro-endocrine tumors
35. Review parathyroid-hormone-related peptides. A new class of multifunctional proteins
36. Parathyroid hormone-related peptide expression in primary and metastatic liver tumors
37. Hepatic arterial chemoembolization in patients with liver metastases of endocrine tumors: A prospective phase II study in 24 patients
38. Therapie der tumorhypercalc̈mie mit clodronat
39. Hepatic metastases: Percutaneous radio-frequency ablation with cooled-tip electrodes
40. The physiology of parathyroid hormone-related protein
41. Malignant hypercalcemia due to a gastric endocrine cell carcinoma
42. Parathyroid hormone-related peptide in patients with hypercalcemia associated with islet cell carcinoma
43. Treatment of a malignant pancreatic endocrine tumour secreting parathyroid hormone related protein
44. Hypercalcemia of malignancy: The central role of parathyroid hormone-related protein